Mandate

Vinge advises Anyfin in a capital procurement of approximately SEK 320 million

January 18, 2023 M&A

The new financing will be used in order to further strengthen Anyfin’s product portfolio on existing markets in Europe, to accelerate the development of new technology in order to help consumers to save money, and to improve the financial well-being of hundreds of thousands of Europeans.

Anyfin helps its customers to reduce their interest costs by refinancing original loans and providing better offers in respect of the customers’ loans.

Vinge’s team primarily consisted of Johan Larsson, Ellinor Wargenbrant and Nando Basic.

Read more>>>

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025